4.3 Article

Genetic diversity of Aspergillus species isolated from onychomycosis and Aspergillus hongkongensis sp nov., with implications to antifungal susceptibility testing

Journal

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Volume 84, Issue 2, Pages 125-134

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2015.10.027

Keywords

Aspergillus; Aspergillus hongkongensis sp nov.; Onychomycosis; Sequencing; Metabolic fingerprinting; MALDI-TOF MS

Funding

  1. Research Fund for the Control of Infectious Diseases (commissioned project), Food and Health Bureau, the Government of the Hong Kong Special Administrative Region, Hong Kong
  2. Strategic Research Theme Fund, The University of Hong Kong, Hong Kong
  3. Small Project Fund, The University of Hong Kong, Hong Kong
  4. Mary Sun Medical Scholarship, The University of Hong Kong, Hong Kong
  5. Wong Ching Yee Medical Postgraduate Scholarship, The University of Hong Kong, Hong Kong
  6. University Postgraduate Scholarship, The University of Hong Kong, Hong Kong
  7. Croucher Senior Medical Research Fellowship, Croucher Foundation, Hong Kong

Ask authors/readers for more resources

Thirteen Aspergillus isolates recovered from nails of 13 patients (fingernails, n = 2; toenails, n = 11) with onychomycosis were characterized. Twelve strains were identified by multilocus sequencing as Aspergillus spp. (Aspergillus sydowii [n = 4], Aspergillus welwitschiae [n = 3], Aspergillus terreus [n = 2], Aspergillus flavus [n = 1], Aspergillus tubingensis [n = 1], and Aspergillus unguis [n = 1]). Isolates of A. terreus, A. flavus, and A. unguis were also identifiable by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The 13th isolate (HKU49(T)) possessed unique morphological characteristics different from other Aspergillus spp. Molecular characterization also unambiguously showed that HKU49T was distinct from other Aspergillus spp. We propose the novel species Aspergillus hongkongensis to describe this previously unknown fungus. Anti fungal susceptibility testing showed most Aspergillus isolates had low MICs against itraconazole and voriconazole, but all Aspergillus isolates had high MICs against fluconazole. A diverse spectrum of Aspergillus species is associated with onychomycosis. Itraconazole and voriconazole are probably better drug options for Aspergillus onychomycosis. (C) 2016 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available